Demonstrates how dual-purpose therapeutic targets may address both hepatocellular carcinoma progression and cellular ...

Demonstrates how dual-purpose therapeutic targets may address both hepatocellular carcinoma progression and cellular senescence ...

A single thermal performance curve applies across life, from bacteria to animals. Species differ in optimal temperatures, but ...

A high-resolution groundwater map shows how underground water varies across the U.S., with new insights for agriculture and ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes. Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage ...

Learn to manage anxiety in advanced Parkinson's with treatments like therapy, medication, lifestyle changes, and more to ...

As claims handling grows more complex and cost pressures continue to rise, insurers, MGAs, and risk managers are taking a closer look at how Third-Party Administrators (TPAs) influence outcomes across ...

European Commission approves Sanofi’s Teizeild to treat patients with stage 2 type 1 diabetes: Paris Tuesday, January 13, 2026, 11:00 Hrs [IST] The European Commission has appro ...

Peer-reviewed publication in “The Oncologist” is now available onlineInvestigational same-day dosing of Rolvedon demonstrated a clinical response and adverse event profile similar to next-day ...

Plasma Wakefield Accelerators (PWFA) represent a disruptive candidate for next-generation high-energy accelerators. By ...